Association between intravenous tirofiban and intracranial hemorrhage in acute large vessel occlusion stroke: insight from the RESCUE BT randomized placebo-controlled trial

ConclusionsIn patients with acute large vessel occlusion stroke, intravenous tirofiban before EVT within 24  h of time from last known well is not associated with increased risk of SICH. Patients who are older, have more severe neurological deficits, or with cardioembolism are at higher risk of SICH with intravenous tirofiban.Trial registration numberURL:http://www.chictr.org.cn; Unique identifier: ChiCTR-INR-17014167.
Source: Journal of Neurology - Category: Neurology Source Type: research